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Abstract
Background: Successful	 preclinical	 transplantations	 of	 porcine	 hearts	 into	 baboon	
recipients	are	required	before	commencing	clinical	trials.	Despite	years	of	research,	
over half of the orthotopic cardiac xenografts were lost during the first 48 hours 
after transplantation, primarily caused by perioperative cardiac xenograft dysfunc-
tion	(PCXD).	To	decrease	the	rate	of	PCXD,	we	adopted	a	preservation	technique	of	
cold	non-ischemic	perfusion	for	our	ongoing	pig-to-baboon	cardiac	xenotransplanta-
tion project.
Methods: Fourteen	orthotopic	cardiac	xenotransplantation	experiments	were	carried	
out	with	genetically	modified	juvenile	pigs	(GGTA1-	KO/hCD46/hTBM)	as	donors	and	
captive-bred	baboons	as	recipients.	Organ	preservation	was	compared	according	to	
the	two	techniques	applied:	cold	static	ischemic	cardioplegia	(IC;	n	=	5)	and	cold	non-
ischemic	 continuous	perfusion	 (CP;	n	=	 9)	with	 an	oxygenated	albumin-containing	
hyperoncotic cardioplegic solution containing nutrients, erythrocytes and hormones. 
Prior	 to	 surgery,	we	measured	 serum	 levels	 of	 preformed	anti-non-Gal-antibodies.	
During surgery, hemodynamic parameters were monitored with transpulmonary 
thermodilution. Central venous blood gas analyses were taken at regular intervals to 
estimate oxygen extraction, as well as lactate production. After surgery, we measured 
troponine T and serum parameters of the recipient’s kidney, liver and coagulation 
functions.
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1  | INTRODUC TION
Cardiac allotransplantation is the best available treatment option for 
patients with severe terminal heart disease. Organ demand, how-
ever, exceeds the available supply.1,2 Xenotransplantation of genet-
ically modified porcine organs might offer a solution to the existing 
organ shortage.3	 Recently,	 we	 reported	 on	 non-human	 primates	
which, after having received genetically modified porcine heart re-
placements, survived consistently for more than 3 months,4 a period 
proposed	as	one	prerequisite	before	initiating	a	clinical	trial.5 In this 
context, a key challenge to be mastered is donor organ preservation 
to overcome primary graft failure.
For	organ	preservation,	 antegrade	 flushing	of	 the	coronary	ar-
teries with cardioplegic solution followed by ischemic storage at 4°C 
is the standard for clinical heart transplantation.6 In this context, 
ischemia lasting <4 hours is associated with higher survival rates, 
whereas ischemic preservation of more than 6 hours is a risk factor 
for increased mortality within 1 year.1 Hence, better organ protec-
tion is necessary to reduce cardiac metabolism and prevent isch-
emia-reperfusion	injury.7 Although a variety of clinical cardioplegic 
solutions have been used,8 analyses of their effectiveness yielded 
controversial results,6 suggesting that none of the currently avail-
able compounds had a clear advantage when compared to others. 
At	present,	histidine-tryptophan-ketoglutarate	(HTK),	University	of	
Wisconsin	(UW),	and	Celsior	solutions	are	commonly	used	for	pres-
ervation in human allotransplantation.6,8
With	 ischemic	 preservation,	 perioperative	 graft	 dysfunction	
occurs	 in	 3.8%-7.4%	 of	 human	 allotransplantations.9,10 After or-
thotopic cardiac xenotransplantation, however, early graft failure is 
much	more	 frequent,	 posing	 a	 barrier	 to	 consistent	 survival	 since	
mortality	has	been	reported	to	be	within	the	range	of	40%-60%.11 
This phenomenon has been coined “perioperative cardiac xenograft 
dysfunction”	(PCXD).
Recently,	Steen	et	al12 reported successful orthotopic allotrans-
plantion of pig hearts after 24 hours of preservation. They perfused 
donor hearts with an oxygenated 8°C cold hyperoncotic cardiople-
gic nutritive solution that contained hormones and erythrocytes. 
After explantation, the grafts were stored in a heart preservation 
system, where they were further perfused for 24 hours with the 
same solution before being transplanted into a recipient pig. After 
transplantation all recipient pigs were stable with normal blood pres-
sures without inotropic support, normal urine production, and nor-
mal	blood	gases,	indicating	adequate	organ	perfusion.12 In another 
study using the same method of organ preservation, the porcine 
hearts	kept	normal	coronary	artery	endothelium-dependent	 relax-
ation and myocardial contractility without edema formation.13	Very	
recently, a phase 2 trial demonstrated the feasibility and safety of 
non-ischemic	heart	preservation	 in	human	heart	 transplantation.14 
Funding information
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Results: In porcine grafts preserved with IC, we found significantly depressed sys-
tolic cardiac function after transplantation which did not recover despite increasing 
inotropic	support.	Postoperative	oxygen	extraction	and	lactate	production	were	sig-
nificantly increased. Troponin T, creatinine, aspartate aminotransferase levels were 
pathologically high, whereas prothrombin ratios were abnormally low. In three of five 
IC	experiments,	PCXD	developed	within	24	hours.	By	contrast,	all	nine	hearts	pre-
served	with	CP	retained	fully	preserved	systolic	function,	none	showed	any	signs	of	
PCXD.	Oxygen	extraction	was	within	normal	ranges;	serum	lactate	as	well	as	parame-
ters	of	organ	functions	were	only	mildly	elevated.	Preformed	anti-non-Gal-antibodies	
were	similar	in	recipients	receiving	grafts	from	either	IC	or	CP	preservation.
Conclusions: While	 standard	 ischemic	 cardioplegia	 solutions	 have	 been	 used	with	
great success in human allotransplantation over many years, our data indicate that 
they are insufficient for preservation of porcine hearts transplanted into baboons: 
Ischemic storage caused severe impairment of cardiac function and decreased tis-
sue	oxygen	supply,	leading	to	multi-organ	failure	in	more	than	half	of	the	xenotrans-
plantation	 experiments.	 In	 contrast,	 cold	 non-ischemic	 heart	 preservation	 with	
continuous perfusion reliably prevented early graft failure. Consistent survival in the 
perioperative	 phase	 is	 a	 prerequisite	 for	 preclinical	 long-term	 results	 after	 cardiac	
xenotransplantation.
K E Y W O R D S
cardiac transplantation, heart preservation, perioperative cardiac xenograft dysfunction, 
xenotransplantation
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To improve graft survival in xenotransplantation, we applied the 
Steen	method	 to	 our	 studies	 by	 perfusing	 the	 donor	 hearts	 with	
the same specific solution for donor organ explantation, followed 
by immediate continuous perfusion; during implantation, the donor 
organs were perfused intermittently.
The primary findings of our recent experiments in orthotopic 
cardiac xenotransplantation were published elsewhere.4 Here, we 
will focus on the immediate outcomes of this approach and discuss 
the	effect	of	non-ischemic	heart	preservation	on	PCXD.
2  | METHODS
2.1 | Animals
Hearts	 from	 14	 juvenile	 pigs	 (German	 Landrace/Large	 White),	
homozygous	 for	 alpha-1,3-galactosyltransferase	 knockout	
(GGTA1-KO),	and	hemizygous	transgenic	for	human	CD46	(hCD46)	
and	 human	 thrombomodulin	 (hTBM)	 (Revivicor,	 Blacksburg,	 USA,	
and	 Institute	 of	 Molecular	 Animal	 Breeding	 and	 Biotechnology	
Gene	Center,	LMU	Munich,	Germany)	were	transplanted	into	male	
captive-bred	baboons	 (Papio anubis;	German	Primate	Centre	DPZ).	
Localization	and	stability	of	hCD46	and	hTBM	expression	were	veri-
fied	post-mortem.4
2.2 | Anesthesia
Transthoracic echocardiographic examinations of the donor pigs 
were carried out 1 week prior to surgery to exclude congenital heart 
defects. All animals were fasted for 12 hours prior to anesthesia. 
Following	intramuscular	premedication,	general	anesthesia	of	both	
baboons and pigs was induced with intravenous bolus administra-
tions	 of	 propofol	 (Propofol-Lipuro	 2%,	 B.	 Braun	 Melsungen	 AG)	
and	 fentanyl	 (Fentanyl-Janssen;	 Janssen-Cilag	 GmbH).	 Anesthesia	
was	maintained	with	 either	 continuous	 infusions	 of	 propofol	 (0.1-
0.2	mg/kg/min)	or	inhalation	of	sevoflurane	(1-2	vol%	endexpiratory;	
sevorane,	AbbVie	Germany	GmbH	&	Co.	KG).	Analgesia	was	main-
tained	with	 repetitive	bolus	administrations	of	 fentanyl	 (2.5-8	µg/
kg	every	30-45	minutes).	After	endotracheal	intubation,	the	animals	
were	 mechanically	 ventilated.	 During	 anesthesia,	 ECG	 and	 blood	
pressure	were	monitored	and	ventilation	adjusted	to	end-tidal	CO2 
as	 necessary.	 Post-operatively,	 transthoracic	 echocardiographic	
examinations of the transplanted graft were carried out at regular 
intervals.
2.3 | Surgical procedures
After	median	sternotomy,	the	donor	pigs	were	heparinized	(500	IU/
kg;	heparin-natrium-25000-ratiopharm,	Ratiopharm	GmbH).	The	as-
cending	aorta	was	cannulated	and	cross-clamped.	Cardioplegia	was	
then initiated proximally, using either standard crystalloid solution 
or	continuous	non-ischemic	perfusion	(see	below	for	further	infor-
mation).	The	porcine	hearts	were	excised	and	stored	until	needed	
for implantation.
Median	 sternotomy	 of	 the	 recipient	 baboon	 was	 performed	
in	 general	 anesthesia.	 Following	 heparinization	 (500	 IU/kg),	 the	
ascending aorta and both venae cavae were cannulated and con-
nected	 to	 the	 heart-lung	machine.	 Cardiopulmonary	 bypass	 (CPB)	
commenced,	 at	34°C	 the	ascending	aorta	was	 cross-clamped,	 and	
the	donor	heart	transplanted	using	the	technique	of	Shumway	and	
Lower.15
2.4 | Donor heart preservation
Static	 ischemic	 heart	 preservation	 (IC,	 ischemic	 cardioplegia)	 was	
initiated using 20 mL/kg 4°C unmodified crystalloid cardioplegic so-
lutions,	either	Custodial	HTK	(Dr	F.	Köhler	Chemie	GmbH)	or	Belzer	
UW	 solution	 (Preservation	 Solutions	 Inc).	 Following	 excision,	 the	
heart was submersed in cardioplegic solution and stored on ice.
Non-ischemic	 continuous	 preservation	 (CP)	 was	 initiated	 using	
antegrade aortic perfusion at 20 mm Hg with 600 mL 8°C cold pres-
ervation	 medium	 (oxygenated	 albumin-containing	 hyperoncotic	
cardioplegic solution with hormones, erythrocytes, and additional in-
gredients	as	shown	in	Table	1	Ref.	12).	The	asystolic	heart	was	then	
excised and a large cannula was inserted into the ascending aorta. 
Continuous perfusion with the preservation medium was then pro-
vided by an extracorporeal heart preservation system consisting of 
a	pressure-	and	flow-controlled	roller	pump,	an	O2/CO2-exchanger,	a	
TA B L E  1   Composition of the perfusion medium used for 
continuous	non-ischemic	preservation	of	donor	hearts,	as	
described	by	Steen	et	al12
Na+ 136 mmol/L
K+ 23 mmol/L
Ca2+ 1.3 mmol/L
Mg2+ 8.0 mmol/L
Cl− 142 mmol/L
HCO
−
3
25 mmol/mL
PO
2−
4
1.3 mmol/L
D-Glucose 6.3 mmol/L
Albumin 75 g/L
Cocaine 6 nmol/L
Noradrenaline 6 nmol/L
Adrenaline 6 nmol/L
T3 3 nmol/L
T4 2 nmol/L
Cortisol 420 nmol/L
Insulin 8 U/L
Imipenem 20 mg/L
Erythrocytes	(Hct) 10%-15%
96% O2 + 5% CO2 0.2 L/min
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leukocyte filter, an arterial filter, and a cooler/heater unit as described 
elsewhere in more detail.12 To prevent left ventricular dilation during 
perfusion, the mitral valve was made incompetent using a plastic tube. 
The	heart	was	then	submersed	into	the	heart-lung-machine’s	reservoir	
filled with approximately 3 L of preservation medium at a temperature 
of 8°C. During preservation, the organ was continuously perfused at a 
pressure of 20 mm Hg; during implantation, perfusion was changed to 
an intermittent mode for 2 minutes every 15 minutes.
2.5 | Immunosuppression
An	 immunosuppressive	 regimen	 based	 on	Mohiuddin	was	 used.16 
In	 short,	 all	 animals	 received	B	 cell–depleting	 anti-CD20	antibody	
(MabThera;	Roche	Pharma	AG),	ATG	(Thymoglobulin;	Sanofi-Aventis	
GmbH),	and	either	anti-CD40	monoclonal	antibody	(mouse/rhesus	
chimeric	 IgG4	 clone	 2C10R4,	 NIH	 Non-human	 Primate	 Reagent	
Resource,	MassBiologicalsUSA;	courtesy	of	K.	Reimann)	or	human-
ized	αCD40L	PAS	Fab	 (XL-protein	GmbH	and	Wacker-Chemie)	 for	
induction therapy. Immunosuppression was maintained with my-
cophenolate	mofetil	(CellCept,	Roche),	either	anti-CD40	monoclonal	
or αCD40L	PASylated	Fab,	and	methylprednisolone	(Urbason	solu-
ble,	Sanofi-Aventis,	Germany	GmbH).
2.6 | Hemodynamic monitoring of the recipient
For	continuous	hemodynamic	measurements,	a	central	venous	cath-
eter	was	placed	into	the	internal	jugular	vein	(Arrow	International),	
an	 arterial	 catheter	 (Thermodilution	 Pulsiocath;	 Pulsion	 Medical	
Systems)	into	the	right	femoral	artery.	Cardiac	output	(CO)	was	as-
sessed by transpulmonary thermodilution and indexed to body sur-
face area using the formula 0.083 ×	B0.639,	where	B	is	body	weight	in	
kg17	to	obtain	the	cardiac	index	(CI).	Hemodynamic	measurements	
were done in triplets at a steady state: after induction of anesthesia, 
one	hour	after	weaning	from	CPB,	after	closing	the	chest,	and	before	
removing	the	arterial	catheter.	Data	were	recorded	with	PiCCOWin	
software	(Pulsion	Medical	Systems).
2.7 | Blood gas analyses and laboratory tests
Central venous oxygen saturation (scvO2	[%])	and	lactate	[mmol/L]	were	
measured before surgery and at regular intervals after weaning from 
CPB	(RAPIDlab®	1265,	Siemens).	Blood	samples	testing	major	organ	
functions	were	taken	in	the	morning	of	the	first	post-operative	day	or	
before euthanasia, if the experiment had to be terminated earlier.
2.8 | Anti-non-Gal antibody titers of the recipient
Preoperative	 plasma	 titers	 of	 anti-non-Gal	 IgM	 and	 IgG	 antibod-
ies were measured by flow cytometry following the consensus 
protocol published previously18 and described in more detail else-
where.4 In brief, aortic endothelial cells of genetically modified pigs 
(GTTA1-KO/hCD46/hTBM)	 were	 incubated	 with	 diluted	 baboon	
plasma. After washing with cold staining buffer, the cells were in-
cubated	with	goat	 anti-human	 IgM-RPE	 (SouthernBiotech)	or	goat	
anti-human	 IgG-FITC	 (Thermo	 Fisher	 Scientific).	 After	 rewashing	
and	 resuspending,	 fluorescence	 was	 acquired	 on	 FACS	 LSRII	 (BD	
Biosciences).	Data	were	analyzed	using	FlowJo	software	for	detec-
tion	of	mean	fluorescence	intensity	in	the	FITC	or	RPE	channel.
2.9 | Statistics
Data	analysis	was	performed	with	GraphPad	Prism	8.0	 (GraphPad	
Software	Inc).	For	analysis	of	two	independent	factors	in	repeatedly	
measured animals, a mixed model using a compound symmetry co-
variance matrix which is fit using restricted maximum likelihood was 
applied. This mixed model can manage missing values in contrast 
to	a	 repeated	measures	 (RM)	 two-way	ANOVA.	 In	 the	absence	of	
missing values, this method gives the same p values and multiple 
comparisons	 tests	 as	RM	ANOVA.	 In	 the	presence	of	missing	val-
ues	 (missing	completely	at	 random),	 the	results	can	be	 interpreted	
like	a	RM	ANOVA.	Statistically	significant	differences	between	two	
independent	 groups	 were	 determined	 using	 unpaired	 two-sided	
Student’s	t tests. Data are presented as single measurements with 
group means ±	 standard	 deviations	 (SD).	P < .05 was considered 
significant.
2.10 | Study approval
The study was carried out according to the European Law on 
Protection	of	Animals	for	Scientific	Purposes	and	was	approved	by	
the	Government	of	Upper	Bavaria,	Germany.	Care	of	the	animals	was	
in	accordance	with	 the	Guide	 for	 the	Care	and	Use	of	Laboratory	
Animals	 prepared	 by	 the	National	 Academy	 of	 Sciences	 and	 pub-
lished	by	the	National	Institutes	of	Health	(NIH	publication	No.	85-
23,	1985)	and	the	German	Law	for	the	Care	of	Experimental	Animals	
(German	Legislation	for	the	Welfare	of	Laboratory	Animals,	article	5,	
§7	-	§9a,	revised	2006).
3  | RESULTS
3.1 | Initial donor graft function
Table	2	summarizes	perfusion	methods,	perfusion	 times,	 initial	graft	
function,	and	survival	times	of	the	individual	experiments.	For	IC,	HTK	
solution (n =	3)	and	UW	solution	 (n	=	2)	were	used	as	cardioplegia.	
Mean	total	ischemia	time	in	this	group	was	123	± 7 minutes. All organs 
preserved	with	HTK	showed	severely	impaired	function	after	CPB	and	
the grafts failed within 24 hours; two animals could not be weaned 
from respirator due to hemodynamic instability. Organs preserved 
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with	UW	solution	showed	good	(ID	16755)	or	moderately	impaired	(ID	
16752)	function.	 In	the	case	of	 ID	16755,	cardiac	function	remained	
unchanged during the first 72 hours, whereas experiment ID 16752 
had	to	be	terminated	after	72	hours	due	to	multi-organ	failure.
In	 CP-preserved	 organs,	 mean	 out-of-body	 organ	 perfusion	
times were 213 ± 35 minutes, of which continuous perfusion time 
inside the preservation system accounted for 102 ± 34 minutes. 
Organ	preparation	and	anastomosis	time	was	similar	to	that	of	 IC-
preserved hearts (111 ± 27 minutes; P =	 .3920).	In	contrast	to	the	
IC	group,	all	CP	animals	were	successfully	extubated	and	suture-ex-
tubation time was significantly shorter (median 785 minutes vs 
296 minutes; P =	.0276,	log-rank	test).	Organ	function	remained	ex-
cellent throughout the first 72 hours in all experiments.
Collectively,	these	data	suggest	that	CP	is	superior	to	IC	in	this	
xenotransplantation setting.
3.2 | Catecholamine support in 
transplanted baboons
All animals needed catecholamine support for several hours after 
weaning	 from	 CPB	 (Table	 3,	 Figure	 1A).	 Noradrenaline,	 a	 primar-
ily vasopressor agent administered to counteract vasodilation 
caused	 by	 anesthesia,	 extracorporeal	 circulation,	 and	 ischemia-
reperfusion injury, was gradually reduced over time in both groups 
(F(3,36)	= 5.679, P =	 .0027).	 However,	 vasopressor	 demand	 after	
TA B L E  2  Overview	of	preservation	method,	ischemic	times,	continuous	and	intermittent	perfusion	times,	initial	function,	suture-
extubation time, and survival of cardiac grafts after orthotopic xenotransplantation
ID
Preservation 
method
Ischemia 
time (min)
Perfusion time (min)
Initial graft 
function
Suture-extubation 
(min)
Post-operative 
survival (d)Continuous Intermittent
16752 IC	(UW) 124 n/a n/a Moderately	
impaired
377 3
16754 IC	(HTK) 128 n/a n/a Severely	
impaired
Not extubated 1
16755 IC	(UW) 112 n/a n/a Good 264 30
16751 IC	(HTK) 121 n/a n/a Severely	
impaired
785 1
16753 IC	(HTK) 128 n/a n/a Severely	
impaired
Not extubated 1
16048 CP n/a 44 114 Good 256 18
17138 CP n/a 85 178 Good 320 4
17140 CP n/a 94 105 Good 326 27
17139 CP n/a 91 112 Good 296 40
17187 CP n/a 96 99 Good 207 51
17290 CP n/a 86 94 Good 254 90
17186 CP n/a 124 120 Good 414 90
17493 CP n/a 161 87 Good 390 195
17491 CP n/a 136 94 Good 293 182
Abbreviations:	CP,	continuous	perfusion;	HTK,	histidine-tryptophan-ketoglutarate;	IC,	ischemic	cardioplegia;	UW,	University	of	Wisconsin.
Parameter Time point
Ischemic 
cardioplegia
Continuous 
perfusion
Mean ± SD n Mean ± SD n
Noradrenalin [µg/kg/min] Weaning	from	CPB 0.14 ± 0.05 5 0.07 ± 0.06 9
1	h	after	CPB 0.12 ± 0.05 5 0.02 ± 0.02 9
2	h	after	CPB 0.10 ± 0.06 5 0.02 ± 0.02 9
3	h	after	CPB 0.08 ± 0.08 5 0.02 ± 0.03 9
Adrenalin [µg/kg/min] Weaning	from	CPB 0.05 ± 0.04 5 0.04 ± 0.02 9
1	h	after	CPB 0.15 ± 0.08 5 0.04 ± 0.05 9
2	h	after	CPB 0.18 ± 0.14 5 0.02 ± 0.03 9
3	h	after	CPB 0.30 ± 0.38 5 0.02 ± 0.03 9
TA B L E  3   Catecholamine support 
before, during, and after orthotopic 
xenotransplantation of porcine 
hearts preserved with either ischemic 
cardioplegia or continuous perfusion. 
Data presented as mean ±	SD
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CPB	 was	 significantly	 higher	 in	 animals	 with	 IC-preserved	 grafts,	
indicating	 that	 ischemia-reperfusion	 injury	 was	 more	 pronounced	
when	compared	to	CP	preservation	(F(1,12)	= 15.14, P =	.0021).
All animals were treated with adrenaline after weaning from 
CPB	 to	 improve	 cardiac	 contractility	 (Table	 3,	 Figure	 1B).	Overall,	
IC-preserved	 hearts	 needed	 up	 to	 15	 times	 more	 inotropic	 sup-
port	than	CP-preserved	hearts	(F(1,12)	= 7.724, P =	.0167).	We	also	
observed a significant interaction between the preservation tech-
niques	and	 time	 (F(3,36)	= 4.184, P =	 .0122):	 IC-preserved	hearts	
required	increasing	doses	of	adrenaline,	whereas	inotropic	support	
was	reduced	in	recipients	with	CP-preserved	hearts.	This	indicates	
early deterioration of systolic function in the IC group, in contrast to 
quick	recovery	from	CPB	in	the	CP	group.	Notably,	hearts	preserved	
with	UW	solution	needed	little	inotropic	support	(Figure	1B,	gray).
3.3 | Hemodynamics of transplanted baboons
As the hemodynamic parameter of global cardiac performance, CI 
was	measured	before,	during,	and	after	surgery	(Table	4	and	Figure	2).	
In both groups, CI was similar before transplantation. After ortho-
topic transplantation, CI decreased in both groups (F(3,30)	= 10.58, 
P <	 .0001).	However,	CP-preserved	hearts	performed	significantly	
better	 in	 the	 immediate	 post-operative	 period	 than	 IC-preserved	
hearts F(1,12)	= 12.96, P =	.0036).	Animals	with	IC-preserved	hearts	
had a pathologically low CI after transplantation despite increasing 
inotropic support, indicating severe systolic heart failure, and a de-
creasing	ability	to	maintain	adequate	organ	perfusion.	 In	these	re-
cipients,	the	marginal	CI	did	not	recover	after	surgery.	By	contrast,	
those	with	CP-preserved	hearts	had	CIs	that	returned	to	normal	lev-
els	within	several	post-operative	hours	(F(3,30)	= 3.753, P =	.0212).
3.4 | Blood gas analyses
Central venous oxygen saturation measurements were taken to as-
sess the compensatory increase of oxygen extraction from the blood 
when	tissue	oxygen	delivery	is	insufficient.	Table	3	and	Figure	3	show	
ScvO2 levels before, during, and after the transplantation procedure.
In	both	groups,	ScvO2 was similar before transplantation. Along 
with	 the	drop	of	CI,	 ScvO2 significantly decreased after transplan-
tation in all recipients (F(4,42)	= 26.21, P <	 .0001).	In	animals	with	
CP-preserved	organs,	 this	decrease	was	small	and	ScvO2 measure-
ments remained within acceptable ranges. In contrast, animals that 
received	an	IC-preserved	graft	showed	highly	pathological	levels	of	
ScvO2, indicating an excessive oxygen extraction from arterial blood 
(F(1,12)	= 41.54, P <	.0001).	In	the	presence	of	systolic	heart	failure,	
as described by reduced CI, this indicates insufficient tissue oxygen 
delivery.
After	surgery,	ScvO2 levels minimally declined, but remained sta-
ble	within	normal	ranges	in	recipients	with	CP-preserved	hearts.	In	
animals	with	IC-preserved	hearts,	ScvO2 levels increased slowly, but 
remained	pathologically	low	for	the	whole	immediate	post-operative	
period (F(4,42)	= 7.205, P =	.0002).
Serum	lactate	is	considered	a	parameter	of	tissue	hypoperfusion	
and	hypoxia	before,	during,	and	after	surgery	(Table	4	and	Figure	4).	
Both	groups	showed	elevated	levels	of	serum	lactate	after	weaning	
from	CPB	(F(4,45)	= 23.73, P <	.0001).	In	the	CP	group,	post-opera-
tive levels rose only moderately, whereas highly pathological levels 
were reached in the IC group (F(1,12)	= 22.74, P =	.0005),	indicating	
severe	microcirculatory	 hypoperfusion	 and	 hypoxia.	 Furthermore,	
serum	 lactate	 increases	 were	 transient	 in	 the	 animals	 with	 CP-
preserved hearts and levels returned to normal within 12 hours after 
CPB.	In	contrast,	there	was	no	return	to	baseline	in	animals	with	IC-
preserved hearts (F(4,45)	= 15.86, P =<	0.0001).	Notably,	serum	lac-
tate levels remained also low when IC preservation was done with 
UW	solution	(Figure	4,	gray).
3.5 | Laboratory analyses of organ functions
Serum	 levels	of	 the	cardiac	enzyme	troponin	T	were	measured	on	
the first day after orthotopic transplantation to assess cardiomyo-
cyte	damage	(Table	5	and	Figure	5A).	Troponin	T	levels	were	almost	
eight	times	higher	in	the	IC	than	in	the	CP	group	(P =	 .0031),	 indi-
cating	severe	ischemia-reperfusion	injury.	Serum	levels	of	creatinine	
and	 aspartate	 aminotransferase	 (AST),	 and	 the	 prothrombin	 ratio	
were	 measured	 as	 parameters	 to	 estimate	 post-operative	 kidney,	
F I G U R E  1  A,	B,	Catecholamine	support	(A,	noradrenaline;	B,	adrenaline)	at	weaning	and	several	hours	after	cardiopulmonary	bypass	
(CPB).	Donor	hearts	were	either	preserved	with	static	ischemic	cardioplegia	(IC,	black	[histidine-tryptophan-ketoglutarate	solution]	and	gray	
[University	of	Wisconsin	solution])	or	continuous	perfusion	(CP,	red).	Data	are	presented	as	scatter	plots	with	mean	±	SD
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liver,	and	coagulation	function	(Table	5).	Animals	with	IC-preserved	
hearts	had	significantly	higher	serum	levels	of	creatinine	(Figure	5B;	
P =	 .0049)	 and	AST	 (Figure	 5C;	P =	 .0094),	 and	 the	 prothrombin	
ratio	was	decreased	 (Figure	5D;	P =	 .0182).	When	compared	with	
the	CP	group,	these	findings	indicate	multi-organ	dysfunction	due	to	
decreased CO of the failing graft, leading to insufficient delivery of 
oxygen and nutrients to the recipient’s organs.
3.6 | Anti-non-Gal antibody titers
To	 estimate	 preformed	 baboon	 anti-pig	 antibodies	 (Ab)	 as	 a	 pos-
sible cause of early xenograft failure, plasma titers of preformed 
anti-non-Gal	Ab	were	measured	before	transplantation	(Figure	6A,B).	
We	did	not	observe	significant	differences	in	IgM	(P =	.5765)	or	IgG	
(P =	.2449)	Ab	titers	when	comparing	the	two	groups.	This	indicates	
that	 levels	of	pre-existing	antibodies	against	non-Gal	epitopes	had	
no	influence	on	post-operative	graft	dysfunction.
4  | DISCUSSION
4.1 | Non-ischemic preservation prevents PCXD
Perioperative	graft	dysfunction	after	orthotopic	cardiac	xenotrans-
plantation	was	successfully	prevented	by	non-ischemic,	continuous	
Parameter Time point
Ischemic cardioplegia Continuous perfusion
Mean ± SD n Mean ± SD n
CI [L/min/m2] Before	surgery 4.88 ± 0.62 5 4.97 ± 0.75 9
1	h	after	CPB 3.13 ± 1.26 5 4.46 ± 0.73 8
After surgery 2.48 ± 0.74 5 3.88 ± 0.65 8
Catheter removal 2.70 ± 0.87 4 4.93 ± 1.61 6
ScvO2 [%] Before	surgery 84.6 ± 6.5 5 84.2 ± 4.9 9
1	h	after	CPB 41.4 ± 26.1 3 73.3 ± 8.7 6
6	h	after	CPB 40.4 ± 14.9 5 71.0 ± 11.7 9
9	h	after	CPB 44.3 ± 9.1 5 70.6 ± 3.9 9
12	h	after	CPB 48.5 ± 8.5 4 69.7 ± 4.2 9
Lactate [mmol/L] Before	surgery 0.82 ± 0.33 5 0.89 ± 0.22 9
1	h	after	CPB 3.89 ± 3.21 5 1.45 ± 0.54 9
6	h	after	CPB 8.89 ± 4.95 4 1.72 ± 0.58 9
9	h	after	CPB 8.69 ± 3.18 4 2.38 ± 1.79 9
12	h	after	CPB 9.373 ± 5.533 4 1.371 ± 0.898 9
TA B L E  4  Cardiac	index	(CI)	and	central	
venous	oxygen	saturation	(ScvO2)	serum	
lactate levels before, during, and after 
orthotopic xenotransplantation of porcine 
hearts preserved with either ischemic 
cardioplegia or continuous perfusion. 
Data presented as mean ±	SD
F I G U R E  2   Cardiac index before and after orthotopic cardiac 
xenotransplantation. Donor hearts were either preserved with 
static	ischemic	cardioplegia	(IC,	black	[histidine-tryptophan-
ketoglutarate	solution]	and	gray	[University	of	Wisconsin	
solution])	or	continuous	perfusion	(CP,	red).	Data	are	presented	as	
scatterplots with mean ±	SD.	CPB,	cardiopulmonary	bypass
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F I G U R E  3  Central	venous	oxygen	saturation	(ScvO2)	before	and	
several	hours	after	cardiopulmonary	bypass	(CPB).	Donor	hearts	
were either preserved with static ischemic cardioplegia (IC, black 
[histidine-tryptophan-ketoglutarate	solution]	and	gray	[University	
of	Wisconsin	solution])	or	continuous	perfusion	(CP,	red).	Data	are	
presented as scatterplots with mean ±	SD
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perfusion with a hyperoncotic preservation solution containing 
oxygenated erythrocytes. In contrast, clinically applied crystal-
loid	cardioplegia	solutions	such	as	HTK	or	UW	followed	by	cold	is-
chemic preservation failed to protect the xenografts from systolic 
pump failure, despite very short ischemia times even by clinical 
standards (123 ±	7	min).	Under	these	conditions,	graft	failure	rates	
of <10% would have been expected when compared to human al-
lotransplantations.9,10	However,	three	of	five	experiments	with	IC-
preserved xenografts had to be terminated within 48 hours due to 
primary systolic failure; similar percentages have been reported by 
other authors.11
After IC preservation, 60% of the grafts failed to sustain an ade-
quate	circulation	in	spite	of	high	inotropic	and	vasopressor	support,	
and	cardiogenic	shock	was	the	inevitable	outcome	shortly	after	CPB.	
Increased oxygen extraction could not compensate for insufficient 
tissue oxygen delivery, resulting in microcirculatory hypoxia and, 
eventually,	 multi-organ	 failure.	 Overall,	 continuous	 non-ischemic-
graft preservation proved to be superior: cardiac function and tissue 
oxygenation were normal; all nine grafts showed good function, and 
there were no signs of organ dysfunction in the first 48 hours after 
transplantation.
Various	experimental	data	suggest	that	pig	hearts	are	especially	
susceptible	to	cold	ischemia.	Porcine	grafts	preserved	with	cold	crys-
talloid	 solution	 and	 ischemic	 storage	 showed	 failure	 rates	 of	 60%-
100% within 48 hours after cardiac allotransplantations.19,20 In a 
recent study, more than 40% of recipient pigs did not survive 24 hours 
when	HTK	was	used	as	cardioplegic	solution	before	proceeding	with	
orthotopic allotransplantations.21 Hemodynamic measurements in 
the surviving pigs revealed a decrease of CO by half when compared 
to baseline measurements, an observation we also made in the IC 
group. In these allotransplantation studies, the incidence and extent 
of	early	systolic	graft	failure	was	similar	to	that	of	PCXD.
In	contrast,	when	preserving	porcine	hearts	with	non-ischemic	
continuous perfusion, graft function was maintained both after 
allo-	12	and	xenotransplantation,	as	our	data	demonstrate.	We	be-
lieve that a combination of several factors is responsible for these 
superior	results:	(a)	By	adding	oxygenated	erythrocytes	to	the	per-
fusion solution, myocardial ischemia is absent during storage and 
minimized	 during	 implantation.	 (b)	 The	 use	 of	 hypothermia	 and	
cardioplegic solution further reduces the graft’s metabolic needs. 
(c)	Continuous	perfusion	allows	constant	delivery	of	nutrients	and	
removal	of	toxic	metabolites.	(d)	High	oncotic	pressure	in	the	pres-
ervation	 medium	 inhibits	 edema	 formation;	 strict	 pressure-	 and	
flow-controlled	coronary	perfusion	helps	to	reduce	capillary	dam-
age	and	aggravation	of	myocardial	edema.	 (e)	Lastly,	physiological	
levels of catecholamines, cortisol, and thyroid hormones are sub-
stituted in the solution to maintain myocardial energy stores and 
cardiac function after cold preservation22,23; cocaine blocks the 
re-uptake	of	catecholamines	into	the	nerve	terminals,	thereby	en-
suring	physiological	concentrations	around	alpha-	and	beta-recep-
tors in the graft.13
F I G U R E  4  Serum	lactate	levels	before	and	several	hours	after	
cardiopulmonary	bypass	(CPB).	Donor	hearts	were	either	preserved	
with	static	ischemic	cardioplegia	(IC,	black	[histidine-tryptophan-
ketoglutarate	solution]	and	gray	[University	of	Wisconsin	
solution])	or	continuous	perfusion	(CP,	red).	Data	are	presented	as	
scatterplots with mean ±	SD
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Parameter Time point
Ischemic cardioplegia Continuous perfusion
Mean ± SD n Mean ± SD n
Troponin T [ng/mL] Before	surgery 0.013 ± 0.000 4 0.016 ± 0.006 9
1 d after surgery 12.410 ± 8.959 4 1.597 ± 1.098 9
Creatinine [mg/dL] Before	surgery 0.86 ± 0.09 5 0.93 ± 0.19 9
1 d after surgery 2.42 ± 0.77 5 1.20 ± 0.56 9
AST	[U/I] Before	surgery 29 ± 8 5 46 ± 24 9
1 d after surgery 1299 ± 793 5 459 ± 207 9
Prothrombin	ratio	[%] Before	surgery 103 ± 4 5 94 ± 8 9
1 d after surgery 30 ± 19 5 63 ± 22 9
Donor hearts were either preserved with static ischemic cardioplegia or continuous perfusion. 
Data presented as mean ±	SD.
AST,	aspartate	aminotransferase.
TA B L E  5   Laboratory parameters of 
organ function after orthotopic cardiac 
xenotransplantation
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4.2 | Hemodynamic interspecies differences
We	recently	showed	that	the	systemic	vascular	resistance	(SVR)	 is	
twice	as	high	in	anesthetized	baboons	as	compared	to	size-matched,	
juvenile piglets.24	 Elevated	 pulmonary	 vascular	 resistance	 (PVR)	
is an accepted risk factor for right ventricular failure after heart 
transplantation,25,26	 but	 arterial	 hypertension	 and	 increased	 SVR	
have	not	been	associated	with	post-operative	graft	dysfunction	 in	
humans.10	Siepe	et	al	 reported	that	SVR	and	PVR	increased	2-fold	
24 hours after porcine allotransplantation.21 This group concluded 
that in the absence of diminished contractility, vascular resistances 
may be the main cause of myocardial dysfunction.
To	our	understanding,	the	function	of	our	IC-preserved	porcine	
grafts	 was	 severely	 damaged	 by	 prolonged	 ischemia-reperfusion	
injury, resulting in myocardial stunning with reduced contractility 
(“stone	heart”).	Although	hearts	have	the	potential	to	recover	after	
ischemia-reperfusion	 injury,	 such	 dysfunctional	 grafts	 will	 initially	
have	difficulties	providing	a	sufficient	CO.	When	confronted	with	a	
species-specific	afterload	mismatch,	the	donor	hearts	might	not	be	
able to cope with the increased workload, eventually leading to early 
systolic graft failure. Histology of the failed IC grafts is consistent 
with	 changes	 caused	by	 ischemia-reperfusion	damage,	 inadequate	
cardioplegia	 or	 inotropic	 agents	 (Figure	 7):	 multiple	 small	 foci	 of	
myocyte	 injury	with	homogenization	 and	hypereosinophilia	 of	 the	
F I G U R E  5  A-D,	Serum	levels	of	
parameters	for	cardiac	(A),	kidney	(B),	liver	
(C),	and	coagulation	system	(D)	function	
before surgery and on the day after 
orthotopic cardiac xenotransplantation. 
Donor hearts were either preserved with 
static ischemic cardioplegia (IC, black 
[histidine-tryptophan-ketoglutarate	
solution] and gray [University of 
Wisconsin	solution])	or	continuous	
perfusion	(CP,	red).	Data	presented	as	bar	
plots with mean ±	SD,	with	individuals	
shown	as	dots.	Two-sided	unpaired	t	tests,	
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F I G U R E  6  A,B	Preoperative	serum	
levels	of	baboon	IgM	(A)	and	IgG	(B)	anti-
non-Gal	antibodies	of	recipients	which	
received porcine hearts either preserved 
with static ischemic cardioplegia (IC, 
black	[histidine-tryptophan-ketoglutarate	
solution] and gray [University of 
Wisconsin	solution])	or	continuous	
perfusion	(CP,	red).	Data	presented	as	bar	
plots with mean ±	SD,	with	individuals	
shown	as	dots.	Two-sided	unpaired	t	tests,	
P values as indicated
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sarcoplasm, but no signs of acute cellular or hyperacute rejection nor 
inflammatory infiltrate.
With	 CP	 preservation,	 ischemia-reperfusion	 injury	 is	 nearly	
absent, allowing for optimal graft function and coping with the ba-
boon’s	high-pressure	cardiovascular	system.
4.3 | Anti-non-Gal antibodies and 
thromboregulation incompatibilities
Genetically	modified	pigs	with	GGTA1-KO	are	not	prone	to	hypera-
cute	rejections	caused	by	preformed	antibodies	against	galactose-α-
1,3-galactose.	However,	residual	preformed	anti-non-Gal	antibodies	
bind	to	GGTA1-KO	pig	cells	and	are	widely	present	in	humans	and	
non-human	 primates	 such	 as	 baboons.27	 Anti-non-Gal	 antibodies	
have been reported to contribute to early and late graft rejections 
and are likely the primary cause of delayed xenograft rejection.28-31 
In our study, we did not observe any differences in preoperative 
plasma	 levels	 of	 anti-non-Gal	 IgM	 or	 IgG	 antibodies	 between	 the	
two	groups.	Thus,	the	complete	absence	of	any	case	of	PCXD	in	the	
CP	group	suggests	that	anti-non-Gal	antibodies	did	not	cause	PCXD	
in the IC group.
Ischemia-reperfusion	injury	is	believed	to	be	initiated	by	recog-
nition	of	neo-epitopes	exposed	on	 injured	cells,	 leading	 to	activa-
tion of the complement system and acute inflammation, ultimately 
resulting in tissue injury.32 This mechanism might be aggravated 
by incompatibilities between the porcine and primate coagulation 
and complement systems. In our study, donor genetic modifications 
were	 identical	 in	both	groups;	 all	 donor	 animals	were	hemizygous	
transgenic	for	hCD46	and	hTBM,	which	have	been	shown	to	reduce	
any type of rejection reaction as well as thrombotic microangiopa-
thy.33,34 As we did not observe any case of early graft failure in the 
CP	group,	 it	 is	unlikely	that	complement	or	coagulation	 incompati-
bilities	may	cause	PCXD	in	absence	of	ischemia-reperfusion	injury.
4.4 | Differences in cardioplegic solutions for 
ischemic preservation
We	observed	differences	in	immediate	outcome	depending	on	the	
cardioplegia solution applied. However, as only a small number of 
experiments has been done with either solution, these observa-
tions	may	be	arbitrary.	Hearts	preserved	with	HTK	solution	showed	
poor	overall	results;	hearts	preserved	with	UW	solution	seemed	to	
perform	better,	as	indicated	by	lower	catecholamine	support,	post-
operative oxygen extraction, and serum lactate levels. One baboon 
(ID	16755)	was	the	longest	survivor	in	this	group,	whereas	the	other	
one	 (ID	 16752)	 worsened	 when	 conferred	 to	 his	 cage,	 requiring	
high doses of catecholamines over several hours. In the following 
48	hours,	graft	function	fully	recovered.	At	this	point,	multi-organ	
dysfunction had already developed, and the experiment was ter-
minated.	 In	 a	 recent	 meta-analysis	 in	 human	 allotransplantation,	
UW	 was	 associated	 with	 better	 survival	 as	 compared	 to	 HTK.35 
Steen	et	al12 stressed the importance of a hyperoncotic preserva-
tion solution for organ storage to prevent myocardial edema during 
perfusion of cardioplegic hearts. Containing large amounts of the 
colloid	hydroxyethyl	starch,	UW	might	be	the	better	IC	solution	for	
ischemia-sensitive	pig	organs.	However,	no	amount	of	colloid	active	
substances can prevent ischemia, only oxygen can.
4.5 | Limitations
Tissue sampling was not possible immediately at the time points 
of	 hemodynamic	 data	 collection.	Myocardial	 biopsies	 would	 have	
given detailed insights into histological and molecular changes but 
would have endangered the outcome of the experiment (bleeding, 
perforation).
Blood	 gas	 analyses	 and	 hemodynamic	 measurements	 were	
not performed in all experiments at all times due to premature 
F I G U R E  7   Histopathologic evaluation of the left ventricle in ID 16754, ID 16751, and ID 16753 showed largely unremarkable myocardial 
tissue.	There	were	multiple	small	foci	of	myocyte	injury	with	homogenization	and	hypereosinophilia	of	the	sarcoplasm	and	fraying	of	the	
myocyte	border	as	exemplarily	shown	for	PAV56	(arrows).	These	changes	are	consistent	with	myocardial	ischemic	changes	possibly	caused	
by	inotropic	agents,	ischemia-reperfusion	damage,	or	inadequate	cardioplegia.	Noticeably,	no	signs	of	acute	cellular	or	hyperacute	rejection	
were	present,	especially	no	inflammatory	infiltrate.	Scale	bars	indicate	100	µm
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termination	or	technical	reasons.	We	tried	to	compensate	for	miss-
ing values by applying a mixed model for data analysis.
During	 preservation,	 the	 CP-preserved	 hearts	 received	 sev-
eral	 substances	which	 IC-preserved	hearts	 did	 not,	 such	 as	 thy-
roid	 hormones	 and	 catecholamines	 (Table	 1).	We	 did	 not	 try	 to	
improve	standard	cardioplegic	solutions	(HTK,	UW)	for	xenotrans-
plantation	purposes;	with	 such	optimized	 cardioplegic	 solutions,	
more consistent survival after orthotopic cardiac xenotransplan-
tation	might	also	be	feasible.	At	 the	moment,	CP	preservation	 is	
about	100-fold	more	expensive	than	IC	preservation;	in	our	opin-
ion, however, IC preservation of porcine hearts will always carry 
a	higher	 risk	of	 systolic	pump	failure,	 thus	 jeopardizing	both	 the	
outcome of animal experiments and the future success of clinical 
cardiac xenotransplantation.
5  | CONCLUSION
Cold	 non-ischemic	 heart	 preservation	 with	 continuous	 perfusion	
guarantees	 optimal	 xenograft	 function	 in	 the	 early	 post-operative	
period	after	orthotopic	 cardiac	pig-to-baboon	xenotransplantation	
and	thus	prevents	from	PCXD.	Hence,	consistent	long-term	survival	
as	 a	 prerequisite	 for	 clinical	 application	 of	 xenotransplantation	 is	
possible.
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